Industry
Bioperfectus Partners with FIND to Increase COVID-19 Self-Testing Capacity in Low and Middle-Income Countries
Jiangsu Bioperfectus Technologies Co., Ltd. (Shanghai, China), a leading in-vitro diagnostics provider for infectious diseases, has partnered with FIND (Geneva, Switzerland), the global alliance for diagnostics, to accelerate the availability of affordable SARS-CoV-2 self-tests in low- and middle-income countries (LMICs). More...15 Mar 2022
Global Blood Collection Devices Market to Reach USD 7.8 Billion by 2026 Due to Increasing Incidence of Infectious Diseases
The global blood collection devices market is projected to register a CAGR of 6.0% from USD 5.7 billion in 2021 to USD 7.8 billion by 2026, driven primarily by the increasing incidence of infectious diseases, rising number of accidents & trauma cases, emergence of liquid biopsy tests, and demand for blood donations and blood components. However, the complexities of storage and shipping, and lack of skilled professionals are expected to restrain market growth during the forecast period. More...14 Mar 2022
AI-Powered Pathology Can Radically Enhance Diagnostic Accuracy and Treatment Selection
A new collaborative effort will combine artificial intelligence (AI)-based platforms with clinical expertise and multi-modal data to unlock a broad implementation of next-generation pathology diagnostics. More...14 Mar 2022
Consortium for Analytic Standardization in Immunohistochemistry (IHC) Launched to Improve Patient IHC Test Accuracy
The Consortium for Analytic Standardization in Immunohistochemistry (CASI), launched by Boston Cell Standards (Boston, MA, USA; www.bostoncellstandards.com), is led by an international panel of pathologists and scientists, with a mission to integrate analytic reference standards into immunohistochemistry (IHC), a test format widely used in surgical pathology to evaluate cancers in tissue samples and determine correct treatment. More...11 Mar 2022
Eli Lilly and Quanterix Collaborate to Advance Alzheimer's Blood-Based Biomarkers into Routine Clinical Use
Eli Lilly and Company (Lilly, Indianapolis, IN, USA) and Quanterix Corporation (Billerica, MA, USA) have entered into a collaboration to advance the diagnosis, monitoring and treatment of Alzheimer’s disease. As part of the collaboration, Quanterix will receive a non-exclusive, world-wide license to Lilly’s proprietary P-tau217 antibody technology for potential near-term use in research use only products and services, and future in vitro diagnostic applications. The parties have also entered into a collaboration agreement, which establishes a framework for future projects focused on the development of Simoa immunoassays. More...09 Mar 2022
Global Artificial Intelligence in Diagnostics Market to Surpass USD 5.6 Billion by 2027
The global artificial intelligence (AI) in diagnostics market was valued at USD 300 million in 2020 and is expected to register a CAGR of around 33.5% over the period 2022 to 2027 to surpass USD 5.6 billion by 2027. The market growth will be driven by increasing interest in lowering the cost of disease determination, improving patient consideration, reducing machine personnel time, growing interest in AI, and the need for cost effective symptomatic advancements and approaches, as well as proficient report investigation. More...08 Mar 2022
Medix Biochemica Launches Refreshed and Expanding Brand to Reflect Growing IVD Products Portfolio
Medix Biochemica (Finland) is launching a rejuvenated brand to reflect both the improvements to its offering as a result of recent acquisitions, and its ongoing commitment to the in vitro diagnostics (IVD) industry. More...04 Mar 2022
New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Steam Sterilizer
Hi Vac II Line
New
Urine Analyzer
respons® UDS100
In Other News
Registrations Open for 2022 AACC Annual Scientific Meeting & Clinical Lab Expo
Alcor Scientific Partners with Health Care Investor Water Street to Accelerate Expansion
Globe Scientific Unveils New Laboratory Glassware Line with Superior Packaging
AACC and Life Diagnostics Partner to Relaunch AACC Middle East
Becton Dickinson Acquires Clinical Flow Cytometry Firm Cytognos from Vitro S.A.
Global Cardiac POC Testing Devices Market Driven by Increasing Demand for Troponin Tests
Global Immunofluorescence Assay (IFA) Market to Surpass USD 4 Billion by 2028 Due to Growing Burden of Infectious Diseases
Illumina and Boehringer Ingelheim Partner to Develop Companion Diagnostics (CDx) for Cancer Treatment
Thermo Fisher and Oncocyte to Jointly Develop IVD Test Kits and Companion Diagnostic Tests in Precision Oncology
Global Coagulation Analyzers Market Driven by Growing Awareness About Timely Diagnosis of Blood Clots
Medlab Middle East to Reveal Latest Innovations and Technologies in Mobile Labs for COVID-19 Testing
Global Coagulometers Market to Be Driven by Rising Prevalence of Blood Disorders
Medlab Middle East to Return as Standalone Event in 2023
Global Clinical Immunoanalyzers Market to Be Driven by High Incidence of Chronic and Infectious Diseases
Global Point-of-Care Molecular Diagnostics Market to Be Driven by Rising Instances of Infectious Diseases
Quidel Signs Definitive Agreement to Acquire Ortho Clinical Diagnostics
Clinical Laboratory Tests Market Driven by Demand for Molecular, Pathological and Immunological Testing
Global In-Vitro Diagnostics (IVD) Market to Surpass USD 115 Billion in 2028 Due to Increasing COVID-19 Test Volumes
Global POC Diagnostics Market to Reach Nearly USD 90 Billion Due to Growing Demand for Rapid COVID-19 Test Kits
Eurofins Acquires Genetic Lab Co. to Enhance Clinical and COVID-19 Testing Offering in Japan
Global Point-of-Care Coagulation Testing Market to Be Driven by Growing Geriatric Population
Global HBA1c Laboratory Tests Market Driven by Rise in Diabetic Population
Roche Completes Acquisition of TIB Molbiol Group
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
